Latest / Stock Movers / BP Bonanza, Barclays Down, Novartis Falls
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio News, The Stock Movers Report,
- 0:10Speaker 1: your roundup of companies making moves in the stock market,
- 0:13Speaker 1: harnessing the power of Bloomberg Data.
- 0:16Speaker 2: Let's have a look at some of the stocks on
- 0:17Speaker 2: the move today here in Europe. I'm Caroline Hepka with
- 0:20Speaker 2: Stephen Carroll and we joined by Binberg reporter Clomb Malay.
- 0:23Speaker 2: Good morning as ever, Chloe, good to speak to you.
- 0:26Speaker 2: So Middle East news has been the key worry for
- 0:30Speaker 2: traders this quarter, but BP, of course turning those fears
- 0:34Speaker 2: into gains. How well have they performed?
- 0:38Speaker 3: Yeah? Well as expected. BP has seen a really huge
- 0:41Speaker 3: jump in earnings in the first quarter because of the
- 0:44Speaker 3: Iran war and the huge rising oil prices that the
- 0:47Speaker 3: conflict has triggered. And so it had already flagged before
- 0:50Speaker 3: the earnings that the oil trading performance in the first
- 0:53Speaker 3: quarter had been exceptionals. Today's results really confirmed that net
- 0:57Speaker 3: income more than doubled from a year and beating expectations
- 1:02Speaker 3: as well. And so BP is very well positioned because
- 1:05Speaker 3: its traders are really able to capitalize on this major
- 1:08Speaker 3: disruption in global energy markets. But then at the same time,
- 1:11Speaker 3: it has a relatively small acid base in the Middle East,
- 1:15Speaker 3: which means that is not as affected by big production
- 1:17Speaker 3: cuts as some of its other piers. And so this
- 1:20Speaker 3: will be counted as an early win for the new
- 1:22Speaker 3: Ceomego O'Neil, who started just earlier this month, just on
- 1:26Speaker 3: the first of April. So we'll put her in the
- 1:28Speaker 3: right position to continue with BP's turnaround strategy, which includes,
- 1:33Speaker 3: you know, steps to reduce debt, streamlining the structure, and
- 1:36Speaker 3: of course moving away from those low carbon renewable projects
- 1:40Speaker 3: and investments and really refocusing on oil and gas. And
- 1:43Speaker 3: you know, for now debt is still rising, but that
- 1:46Speaker 3: is not what investors were focused on today. They were
- 1:48Speaker 3: very much focused on this big earnings jump.
- 1:52Speaker 1: To Barclay's next a bit of more of a nuanced
- 1:54Speaker 1: picture from their earnings and shares down about two point
- 1:57Speaker 1: seven percent.
- 1:57Speaker 2: At the moment.
- 1:58Speaker 3: Yeah, for Barclays, the essentially failed to match Wall Street.
- 2:02Speaker 3: So earlier this ending season we had Goldman, Sex City Group, JP, Morgan,
- 2:06Speaker 3: all of these big US banks reporting really massive jumps
- 2:09Speaker 3: in trading revenue because of market volatility, and so the
- 2:12Speaker 3: expectations that was that we would see that replicated in
- 2:16Speaker 3: Europe as well, with European banks, but Barclays did not
- 2:19Speaker 3: quite manage to do that. Equities trading revenue only beat
- 2:22Speaker 3: by a little bit, and then the fixed income trading
- 2:25Speaker 3: was actually below expectations. So that is really weighing on
- 2:28Speaker 3: shares quite a bit this morning, the missing out on
- 2:31Speaker 3: this kind of big trading boost. And then the other
- 2:34Speaker 3: thing weighing on the shares is actually impairments. So Barclays
- 2:37Speaker 3: took an extra one hundred and five million pound provision
- 2:40Speaker 3: for missold carloons, and then this was a big focus
- 2:44Speaker 3: for a debt vestus. It also announced an impairment of
- 2:46Speaker 3: about two hundred million pounds which is said to be
- 2:49Speaker 3: tied to the collapse of Market Financials solution. So in
- 2:53Speaker 3: terms of the provision, this is roughly what the market
- 2:55Speaker 3: was expecting around that two hundred million. But of course
- 2:58Speaker 3: the exposure that Acles has to this big kind of
- 3:01Speaker 3: corporate implosion is obviously not great, and so we are
- 3:04Speaker 3: seeing the ches down this morning.
- 3:06Speaker 2: Okay, there are lots of pressures on the pharmaceutical industry.
- 3:10Speaker 2: Novartis reported this morning, but somewhat disappointing traders.
- 3:14Speaker 3: Why Yeah, so profit and sales both fell in the
- 3:18Speaker 3: first quarter, and so there is Essentially one big challenge
- 3:20Speaker 3: facing ne Vartis and other peers within that pharmer sector,
- 3:24Speaker 3: which is that a lot of its best selling medicines
- 3:26Speaker 3: medicines are facing really are being hit really hard by
- 3:30Speaker 3: a generic competition. So for example, the heart treatment and Trust,
- 3:34Speaker 3: which was once a best seller for nev Artists with
- 3:38Speaker 3: its saw seals plunge more than forty percent in the
- 3:41Speaker 3: first quarter. So the expectation now is that there's new
- 3:44Speaker 3: medicine coming through. You know, we've got a new breast
- 3:46Speaker 3: cancer pill for example, there's a new treatment for prostate
- 3:49Speaker 3: cancer as well that will drive growth in the future
- 3:52Speaker 3: and replace the kind of legacy medicines, and M and
- 3:55Speaker 3: A is also going to be a big part of
- 3:58Speaker 3: growth going forward for nevarta Is. For example, we had
- 4:01Speaker 3: the recent acquisition of Avidity Biosciences, which was the biggest
- 4:05Speaker 3: takeover in more than a decade, and it will give
- 4:08Speaker 3: Nevatis access to a platform that can essentially deliver drugs
- 4:12Speaker 3: directly into muscle cells. And so this is something that
- 4:16Speaker 3: anlysts are saying could lead to multiple blockbuster drugs. So
- 4:19Speaker 3: that is a bright spot for Nevadas. But in the
- 4:21Speaker 3: meantime that generic competition is really hitting those chas enders
- 4:25Speaker 3: earnings hard.
- 4:27Speaker 1: The Stock Movers Report from Bloomberg Radio. Check back with
- 4:31Speaker 1: us throughout the day for the latest roundup of companies
- 4:34Speaker 1: making news on Wall Street and for the latest market
- 4:37Speaker 1: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 4:41Speaker 1: Bloomberg dot com, and on Applecarplay and Android Auto with
- 4:45Speaker 1: the Bloomberg Business app.